512600 — Astal Laboratories Cashflow Statement
0.000.00%
- IN₹845.39m
- IN₹809.51m
- IN₹236.48m
- 21
- 51
- 58
- 38
Annual cashflow statement for Astal Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.281 | 0.081 | -0.171 | 0.321 | 10.9 |
Depreciation | |||||
Non-Cash Items | -2.05 | -2.03 | -2.11 | -1.79 | -0.134 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.189 | -0.068 | -0.355 | -13 | -66.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.99 | -1.86 | -2.49 | -14.4 | -55.9 |
Capital Expenditures | 0 | 0 | 0 | — | -59.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 2.05 | 2.03 | 2.36 | 1.79 | -1.92 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 2.05 | 2.03 | 2.36 | 1.79 | -61.1 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 0 | 0 | 13.2 | 177 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.063 | 0.168 | -0.13 | 0.661 | 59.9 |